Search

Twist Bioscience Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

152.38 1.05

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

148.47

Max

154.81

Pagrindiniai rodikliai

By Trading Economics

Pajamos

9M

-35M

Pardavimai

7.7M

118M

Pelnas, tenkantis vienai akcijai

-0.56

Pelno marža

-29.61

Darbuotojai

979

EBITDA

9.8M

-28M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

-26.03% downside

Dividendai

By Acuity

Kitas uždarbis

2026-11-13

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.5B

8.8B

Ankstesnė atidarymo kaina

151.33

Ankstesnė uždarymo kaina

152.38

Naujienos nuotaikos

By Acuity

50%

50%

167 / 340 reitingas Healthcare

Twist Bioscience Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-25 23:06; UTC

Twist Bioscience Corp shares are higher in after-market hours, rebounding from a post-close low amid broader market support from falling crude oil prices and treasury yields.

2026-08-24 23:51; UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining gains from earlier in the session and staying above key moving averages.

2026-08-21 23:46; UTC

Twist Bioscience Corp shares are lower in after-market trading, despite remaining well above their 20-day moving average and last month's price levels.

2026-08-20 23:46; UTC

Twist Bioscience Corp shares are lower in after-market trading. Broader market pressures, including rising crude oil prices and geopolitical tensions, may be influencing sentiment.

2026-08-19 23:06; UTC

News
Correlated Moves

Twist Bioscience Corp shares are lower in after-market hours following a critical short report from Scorpion Capital questioning the company's AI-driven protein design strategy.

2026-08-18 23:21; UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining an upward trend and positioned above its 20-day moving average.

2026-08-17 22:36; UTC

Twist Bioscience Corp shares are slightly higher in after-market hours, maintaining strong performance above their 20-day moving average despite earlier declines.

2026-08-14 19:06; UTC

Twist Bioscience shares are lower today, continuing a decline since Thursday amid broader market volatility and recent U.S. retail sales data.

2026-08-13 23:06; UTC

Correlated Moves

Twist Bioscience Corp shares are lower in after-market trading, influenced by broader market declines and recent macroeconomic data on jobless claims and producer prices.

2026-08-12 19:16; UTC

Twist Bioscience Corp is higher Wednesday, tracking broader U.S. stock gains amid strength in AI sectors following positive quarterly results from CoreWeave and Super Micro Computer.

2026-08-11 23:46; UTC

Correlated Moves

Twist Bioscience Corp shares declined during after-market hours, following a drop in the Russell 2000 Index amid investor caution ahead of the consumer price index report.

2026-08-10 20:03; UTC

News
Social Media

Twist Bioscience Corp shares are higher today, buoyed by positive social media sentiment and a notable increase in trading volume since Friday's close.

2026-08-07 19:51; UTC

Twist Bioscience Corp shares are higher during Friday's session, with strong market activity and unusually high volume. No specific news explains this movement.

2026-08-06 22:56; UTC

Twist Bioscience Corp shares are higher in after-market trading, reflecting positive momentum since Thursday's close amid broader economic data indicating labor market strength.

2026-08-05 23:56; UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

2026-08-04 23:01; UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

2026-08-03 22:16; UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

2026-07-31 19:56; UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

2026-07-30 10:16; UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

2026-07-29 19:36; UTC

Correlated Moves
Macro Event

Twist Bioscience shares are lower today, influenced by a declining Russell 2000 Index and persistent inflation concerns amid steady interest rates.

2026-07-28 21:56; UTC

Twist Bioscience Corp shares are trading lower in after-market hours. Broader market trends, including declines in Asian semiconductor stocks, may be influencing this movement.

2026-07-27 19:33; UTC

Twist Bioscience Corp shares are lower today, continuing a recent downward trend. The stock pulled back significantly after reaching a session high.

2026-07-24 15:24; UTC

Twist Bioscience Corp shares are lower today, reversing a recent trend of gains. High trading volume accompanies the decline amid mixed economic signals.

2026-07-21 20:02; UTC

Correlated Moves

Twist Bioscience Corp is advancing today, supported by high trading volume and renewed investor interest in technology and AI stocks, despite a pullback earlier in the session.

2026-07-20 23:06; UTC

Twist Bioscience Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Twist Bioscience Corp Prognozė

Kainos tikslas

By TipRanks

-26.03% į apačią

12 mėnesių prognozė

Vidutinis 112 USD  -26.03%

Aukščiausias 120 USD

Žemiausias 102 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Twist Bioscience Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

8

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

167 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat